BH
Biju Haloi
About Biju Haloi
Data last updated:
Biju Haloi has 3 years in corporate governance. Holds Director role. Currently with 2 companies, including Indizeen Pharmaceutical (Opc) Private Limited and Bonarick Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Bonarick Pharmaceutical Private Limited at ₹2.8 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Jun 2023 | 2021 | ₹2.8 Lakh (FY 2022) | Active | |
| Director | 21 Jun 2025 | 2025 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Biju Haloi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biju Haloi
Biju Haloi has 3 years in corporate governance. Holds Director role. Currently with 2 companies, including Indizeen Pharmaceutical (Opc) Private Limited and Bonarick Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Bonarick Pharmaceutical Private Limited at ₹2.8 Lakh (FY 2022).
Biju Haloi is associated with 2 companies as Director, including Bonarick Pharmaceutical Private Limited (₹2.8 Lakh), Indizeen Pharmaceutical (Opc) Private Limited.
Biju Haloi has expertise in General Business.
Biju Haloi has 3 years in corporate governance.
By reported revenue, the largest current company of Biju Haloi is Bonarick Pharmaceutical Private Limited, with revenue of ₹2.8 Lakh (FY 2022).
Biju Haloi currently holds positions at 2 companies: Bonarick Pharmaceutical Private Limited (₹2.8 Lakh), Indizeen Pharmaceutical (Opc) Private Limited.